Arcus Biosciences Inc (RCUS)

Debt-to-capital ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands — — — — — — — — — — — — — — — — — — — —
Total stockholders’ equity US$ in thousands 485,000 565,000 635,000 707,000 462,000 520,000 566,000 600,000 657,000 699,000 747,000 797,000 842,000 542,607 604,555 664,790 502,000 544,417 428,710 140,638
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $485,000K)
= 0.00

Based on the provided data, Arcus Biosciences Inc has consistently maintained a debt-to-capital ratio of 0.00 across all reported quarters from March 31, 2020, to December 31, 2024. A debt-to-capital ratio of 0.00 indicates that the company has no debt in its capital structure during this period. This implies that the company has been financing its operations and investments primarily through equity rather than debt.

Having a debt-to-capital ratio of 0.00 can be viewed positively by investors and creditors as it suggests that the company has a low financial risk associated with debt obligations. It also indicates financial stability and the ability to operate without incurring significant interest expenses. However, it's important to consider the overall financial strategy and the potential impact on profitability and growth in the long term when interpreting this ratio in isolation.